Published in Support Care Cancer on September 17, 2005
Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst (2010) 1.76
Evidence-based pragmatic guidelines for the follow-up of testicular cancer: optimising the detection of relapse. Br J Cancer (2008) 1.01
Negative life events and quality of life in adults with asthma. Thorax (2006) 0.92
Employment status and work-related problems of gastrointestinal cancer patients at diagnosis: a cross-sectional study. BMJ Open (2011) 0.89
Effectiveness of a hospital-based work support intervention for female cancer patients - a multi-centre randomised controlled trial. PLoS One (2013) 0.86
Health-related quality of life, depression, and sexual function in testicular cancer survivors in a developing country: a Serbian experience. Support Care Cancer (2012) 0.81
Paclitaxel-based high-dose chemotherapy with autologous stem cell rescue for relapsed germ cell tumor: clinical outcome and quality of life in long-term survivors. Clin Genitourin Cancer (2012) 0.80
Testicular cancer: a longitudinal pilot study on stress response symptoms and quality of life in couples before and after chemotherapy. Support Care Cancer (2006) 0.80
Use of psychotropic medications by US cancer survivors. Psychooncology (2011) 0.80
Clinical and genetic aspects of testicular germ cell tumours. Hered Cancer Clin Pract (2008) 0.78
The Sound of Silence: A Proxy for Platinum Toxicity. J Clin Oncol (2016) 0.75
Validating the SF-36 health survey questionnaire: new outcome measure for primary care. BMJ (1992) 26.37
The RAND 36-Item Health Survey 1.0. Health Econ (1993) 10.05
Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med (1999) 6.83
Life after breast cancer: understanding women's health-related quality of life and sexual functioning. J Clin Oncol (1998) 4.35
Testicular germ-cell cancer. N Engl J Med (1997) 3.31
Risk of second malignant neoplasms among long-term survivors of testicular cancer. J Natl Cancer Inst (1997) 2.83
Psychosocial and demographic predictors of quality of life in a large sample of cancer patients. Psychooncology (2003) 2.17
Health-related quality of life in chronic disorders: a comparison across studies using the MOS SF-36. Qual Life Res (1998) 1.92
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol (2000) 1.89
Quality of life in long-term survivors of adult-onset cancers. J Natl Cancer Inst (1998) 1.67
Health-related quality of life measured by the EORTC QLQ-C30--reference values from a large sample of Swedish population. Acta Oncol (2000) 1.62
Regular review: Managing testicular cancer. BMJ (2001) 1.43
Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Intern Med (1991) 1.35
Cumulative risk across family stressors: short- and long-term effects for adolescents. J Abnorm Child Psychol (1998) 1.35
Quality of life in long-term survivors of testicular cancer: a population-based case-control study. J Clin Oncol (2002) 1.33
Health-related quality of life in women previously treated for early-stage breast cancer. Psychooncology (2004) 1.33
Fatigue, anxiety, and depression in long-term survivors of testicular cancer. J Clin Oncol (2003) 1.26
Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age. Qual Life Res (2000) 1.15
Health-related worries, self-image, and life outlooks of long-term survivors of childhood cancer. Health Soc Work (2001) 0.98
Psychosocial aspects in long-term survivors of testicular cancer. J Urol (1996) 0.87
Using disease-related and demographic variables to form cancer-distress risk groups. J Behav Med (2001) 0.83
Quality of life of survivors of testicular germ cell cancer: a review of the literature. Support Care Cancer (2004) 0.83
Quality of life after radiotherapy for early-stage testicular seminoma. Radiother Oncol (2001) 0.82
Self-reported satisfaction with life and physical health in long-term cancer survivors and a matched control group. Eur J Cancer B Oral Oncol (1995) 0.80
Problems at social re-integration of long-term cancer survivors. Eur J Cancer (1991) 0.78
Participation behavior of bladder cancer survivors in a medical follow-up survey on quality of life in France. Eur J Epidemiol (2004) 0.75
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
Importance of bleomycin in combination chemotherapy for good-prognosis testicular nonseminoma: a randomized study of the European Organization for Research and Treatment of Cancer Genitourinary Tract Cancer Cooperative Group. J Clin Oncol (1997) 2.29
Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med (2000) 2.19
[Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up]. Ned Tijdschr Geneeskd (2008) 2.06
Shall we operate? Preoperative assessment in elderly cancer patients (PACE) can help. A SIOG surgical task force prospective study. Crit Rev Oncol Hematol (2007) 1.98
Prospective evaluation of early cardiac damage induced by epirubicin-containing adjuvant chemotherapy and locoregional radiotherapy in breast cancer patients. J Clin Oncol (2001) 1.92
Malignant peripheral nerve sheath tumors in patients with and without neurofibromatosis. Eur J Surg Oncol (1995) 1.90
Cardiovascular morbidity in long-term survivors of metastatic testicular cancer. J Clin Oncol (2000) 1.89
The effect of surgical wounding on tumour development. Eur J Surg Oncol (1999) 1.88
Chromosomal damage in peripheral blood lymphocytes of patients treated for testicular cancer. Hum Genet (1990) 1.84
Early development of the metabolic syndrome after chemotherapy for testicular cancer. Ann Oncol (2012) 1.70
Objectives for an internship internal medicine: from the Dutch Blueprint (Raamplan 1994) to implementation into a practical logbook. Neth J Med (1999) 1.70
Soft tissue leiomyosarcomas and malignant gastrointestinal stromal tumors: differences in clinical outcome and expression of multidrug resistance proteins. J Clin Oncol (2000) 1.62
The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis. Cancer Treat Rev (2004) 1.60
Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol (1995) 1.60
Is sentinel node biopsy beneficial in melanoma patients? A report on 200 patients with cutaneous melanoma. Eur J Surg Oncol (2002) 1.54
Treatment-associated leukemia following testicular cancer. J Natl Cancer Inst (2000) 1.54
Cancer, pregnancy and fertility: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2013) 1.52
Infection prevention in granulocytopenic patients by selective decontamination of the digestive tract. Eur J Cancer (1980) 1.52
Continuously infused carboplatin used as radiosensitizer in locally unresectable non-small-cell lung cancer: a multicenter phase III study. Ann Oncol (2004) 1.52
Malignant struma ovarii treated by ovariectomy, thyroidectomy, and 131I administration. Cancer (1987) 1.50
Continuous leakage measurement during hyperthermic isolated limb perfusion. Ann Surg Oncol (2001) 1.49
Comparison of cytogenetic abnormalities and deoxyribonucleic acid ploidy of benign, borderline malignant, and different grades of malignant soft tissue tumors. Lab Invest (1994) 1.44
Syndrome X in testicular-cancer survivors. Lancet (2001) 1.43
Imaging of soft-tissue tumors using L-3-[iodine-123]iodo-alpha-methyl-tyrosine single photon emission computed tomography: comparison with proliferative and mitotic activity, cellularity, and vascularity. Clin Cancer Res (2000) 1.42
Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol (2003) 1.41
Predicting postoperative mortality after colorectal surgery: a novel clinical model. Colorectal Dis (2014) 1.41
5-Fluorouracil/leucovorin/interferon alpha-2a in patients with advanced colorectal cancer. Effects of maintenance therapy on remission duration. Cancer (1995) 1.40
[Myositis as the first manifestation of an exacerbation of Crohn's disease]. Ned Tijdschr Geneeskd (2007) 1.39
[Sentinel lymph node biopsy for melanoma: prognostic value and disadvantages in 300 patients]. Ned Tijdschr Geneeskd (2005) 1.39
Burnout, engagement and resident physicians' self-reported errors. Psychol Health Med (2009) 1.38
Groin dissection in the treatment of lower-extremity melanoma. Short-term and long-term morbidity. Arch Surg (1992) 1.38
Bacteriological aspects of selective decontamination of the digestive tract as a method of infection prevention in granulocytopenic patients. Antimicrob Agents Chemother (1981) 1.37
The current status of S-100B as a biomarker in melanoma. Eur J Surg Oncol (2012) 1.34
Morbidity after inguinal sentinel lymph node biopsy and completion lymph node dissection in patients with cutaneous melanoma. Eur J Surg Oncol (2006) 1.33
Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol (2004) 1.31
Psychological adaptation and social support of parents of pediatric cancer patients: a prospective longitudinal study. J Pediatr Psychol (2001) 1.28
Genetic predisposition to testicular germ-cell tumours. Lancet Oncol (2004) 1.28
Epiphyseal fractures in children treated for osteosarcoma of the femur with chemotherapy, tumourresection, and endoprosthesis: report of four fractures in two children. J Surg Oncol (1984) 1.28
Prevalence of paraneoplastic hyperthyroidism in patients with metastatic non-seminomatous germ-cell tumors. Ann Oncol (2009) 1.25
Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. J Clin Oncol (2004) 1.25
Limb salvage surgery for primary bone sarcoma of the lower extremities: long-term consequences of endoprosthetic reconstructions. Ann Surg Oncol (1998) 1.24
Patient motivation and informed consent in a phase I study of an anticancer agent. Eur J Cancer Clin Oncol (1984) 1.23
Cancer, fertility and pregnancy: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.23
Wound-induced tumor progression: a probable role in recurrence after tumor resection. Arch Surg (1998) 1.22
Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol (2006) 1.21
Detection of unknown occult primary tumors using positron emission tomography. Cancer (1998) 1.18
Aggressive fibromatosis (non-familial desmoid tumour): therapeutic problems and the role of adjuvant radiotherapy. Br J Surg (1995) 1.17
Familial testicular cancer in a single-centre population. Eur J Cancer (1999) 1.17
Phase II study of bleomycin, dacarbazine (DTIC) and vindesine in disseminated malignant melanoma. J Cancer Res Clin Oncol (1989) 1.16
Long-term prognosis of primary retroperitoneal soft tissue sarcoma. Eur J Surg Oncol (2006) 1.15
External and internal hemipelvectomy for sarcomas of the pelvic girdle: consequences of limb-salvage treatment. Eur J Surg Oncol (1997) 1.15
The distribution of drug-efflux pumps, P-gp, BCRP, MRP1 and MRP2, in the normal blood-testis barrier and in primary testicular tumours. Eur J Cancer (2004) 1.14
Locoregional recurrence of retroperitoneal soft tissue sarcoma: second chance of cure for selected patients. Eur J Surg Oncol (2001) 1.13
Sexual functioning after treatment for testicular cancer--review and meta-analysis of 36 empirical studies between 1975-2000. Arch Sex Behav (2001) 1.13
Fluorine-18-fluorodeoxyglucose PET imaging of soft-tissue sarcoma. J Nucl Med (1996) 1.11
Chromosomal analysis and the classification of soft tissue sarcomas. Lab Invest (1989) 1.10
Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma. Cancer (1983) 1.09
The significance of the doctor-patient relationship in coping with cancer. Soc Sci Med (1984) 1.05
Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer. J Clin Oncol (1998) 1.04
Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation. Br J Cancer (2004) 1.04
Soft tissue sarcoma--compliance with guidelines. Cancer (2001) 1.04
Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol (2006) 1.04
Asymptomatic pseudotumours after metal-on-metal hip resurfacing show little change within one year. Bone Joint J (2013) 1.03
The effect of chemotherapy on the growing skeleton. Cancer Treat Rev (2000) 1.03
Therapeutic groin dissection for melanoma: risk factors for short term morbidity. Eur J Surg Oncol (2008) 1.01
Phase II study of bleomycin, actinomycin D, DTIC and vindesine in disseminated malignant melanoma. Eur J Cancer Clin Oncol (1986) 1.01
Osteosarcoma of the pelvis--oncological results of 40 patients registered by The Netherlands Committee on Bone Tumours. Eur J Surg Oncol (2000) 1.01
Ploidy of primary germ cell tumors of the testis. Pathogenetic and clinical relevance. Lab Invest (1989) 1.01
Dermatofibrosarcoma protuberans: recurrence is related to the adequacy of surgical margins. Eur J Surg Oncol (2009) 1.01
Four cycles of BEP versus an alternating regime of PVB and BEP in patients with poor-prognosis metastatic testicular non-seminoma; a randomised study of the EORTC Genitourinary Tract Cancer Cooperative Group. Br J Cancer (1995) 1.00
Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer. Ann Intern Med (1992) 1.00
Microalbuminuria, decreased fibrinolysis, and inflammation as early signs of atherosclerosis in long-term survivors of disseminated testicular cancer. Eur J Cancer (2004) 0.99
Chemotherapy and surgery for locally advanced cancer of the cardia and fundus: phase II study with methotrexate and 5-fluorouracil. Br J Surg (1991) 0.99
Clinico-pathological data and prognostic factors in completely resected AJCC stage I-III liposarcomas. Ann Surg Oncol (2000) 0.99
Dacarbazine (DTIC) and human recombinant interferon alpha 2a (Roferon) in the treatment of disseminated malignant melanoma. Br J Cancer (1990) 0.99
Current treatment for colorectal cancer metastatic to the liver. Eur J Surg Oncol (1999) 0.98
Risk factors for psychological maladjustment of parents of children with cancer. J Am Acad Child Adolesc Psychiatry (1999) 0.98
Fluorodeoxyglucose-positron emission tomography and sentinel lymph node biopsy in staging primary cutaneous melanoma. Eur J Surg Oncol (2003) 0.98
Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. Am J Med Genet A (2004) 0.98
Physical functioning and quality of life after cancer rehabilitation. Int J Rehabil Res (2004) 0.98
Repeated resection of recurrent pulmonary metastatic soft tissue sarcoma. Eur J Surg Oncol (1994) 0.97
Frozen section analysis of sentinel lymph nodes in melanoma patients. Cancer (2000) 0.97
Burnout among Dutch medical residents. Int J Behav Med (2007) 0.97
High-dose etoposide for refractory malignancies: a phase I study. Cancer Treat Rep (1984) 0.96
Role of metallothionein in cisplatin sensitivity of germ-cell tumours. Int J Cancer (2000) 0.96
Brief report: an intervention program for parents of pediatric cancer patients: a randomized controlled trial. J Pediatr Psychol (1998) 0.96